PROPHYLAXIS OF CMV INFECTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH NILOTINIB : A PHASE II TRIAL

被引：0
|
作者：
Lin, C. T. [1 ,2 ]
Wu, S. J. [1 ]
Li, C. C. [1 ,2 ]
Ko, B. S. [1 ]
Yao, M. [1 ]
Lin, W. P. [1 ]
Tang, J. L. [1 ,2 ]
Tien, H. F. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Hematol, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Tai Cheng Stem Cell Therapy Ctr, Taipei 10764, Taiwan
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1107
引用
收藏
页码：423 / 423
页数：1
相关论文
共 50 条
  • [1] Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
    Lin, Chien-Ting
    Hsueh, Po-Ren
    Wu, Shang-Ju
    Yao, Ming
    Ko, Bor-Sheng
    Li, Chi-Cheng
    Hsu, Cheng-An
    Tang, Jih-Luh
    Tien, Hwei-Fang
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (11) : 2310 - 2315
  • [2] Valganciclovir for the prophylaxis of early cytomegalovirus (CMV) infection after allogeneic stem cell transplantation
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 90 - 91
  • [3] Valganciclovir for the early prophylaxis of cytomegalovirus (CMV) infection after allogeneic stem cell transplantation.
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    [J]. BLOOD, 2004, 104 (11) : 352B - 352B
  • [4] Extension of CMV prophylaxis possible after allogeneic stem cell transplantation
    Freyer, Martina
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (04) : 162 - 162
  • [5] Extension of CMV Prophylaxis possible after allogeneic Stem Cell Transplantation
    Freyer, Martina
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (02) : 127 - 127
  • [6] Prophylactic treatment with nilotinib for post-allogeneic stem cell transplantation cytomegalovirus infection: interim analysis of a phase II trial
    Wu, S. J.
    Lin, C. T.
    Lin, W. P.
    Li, C. C.
    Ko, B. S.
    Yao, M.
    Tang, J. L.
    Tien, H. F.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S139 - S139
  • [7] Cytomegalovirus (CMV) infection after allogeneic stem cell transplantation (SCT)
    Trenschel, R
    Ross, S
    Runde, V
    Retzlaff, S
    Ottinger, H
    Kohl, D
    Roggendorf, M
    Schaefer, UW
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S68 - S68
  • [8] Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation
    Maffini, Enrico
    Giaccone, Luisa
    Festuccia, Moreno
    Brunello, Lucia
    Busca, Alessandro
    Bruno, Benedetto
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (06) : 585 - 596
  • [9] Letermovir prophylaxis reduces the risk for CMV reactivation after allogeneic stem cell transplantation
    Koch, K.
    Herhaus, P.
    Osswald, L.
    Braitsch, K.
    Bassermann, F.
    Verbeek, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 62 - 62
  • [10] Letermovir Prophylaxis Reduces The Risk for Cmv Infection After Stem Cell Transplantation
    Koch, Katrin
    Osswald, Lena
    Miller, Isabella
    Braitsch, Krischan
    Herhaus, Peter
    Bassermann, Florian
    Verbeek, Mareike
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 232 - 233
12345